Home Cart Sign in  
Chemical Structure| 961-29-5 Chemical Structure| 961-29-5

Structure of Isoliquiritigenin
CAS No.: 961-29-5

Chemical Structure| 961-29-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoliquiritigenin is an anti-tumor flavonoid from the root of Glycyrrhiza uralensis Fisch., which inhibits aldose reductase with an IC50 of 320 nM and influenza virus replication with an EC50 of 24.7 μM.

Synonyms: GU17; ISL; GU 17, Isoliquiritigenin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isoliquiritigenin

CAS No. :961-29-5
Formula : C15H12O4
M.W : 256.25
SMILES Code : O=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2
Synonyms :
GU17; ISL; GU 17, Isoliquiritigenin
MDL No. :MFCD00075907
InChI Key :DXDRHHKMWQZJHT-FPYGCLRLSA-N
Pubchem ID :638278

Safety of Isoliquiritigenin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Isoliquiritigenin

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NOZ cells 0–100 mM 24 hours, 48 hours, 72 hours ISL significantly inhibited the proliferation of NOZ cells, with IC50 values of 151.3 mmol/L at 24 h, 59.5 mmol/L at 48 h, and 54.2 mmol/L at 72 h. Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220.
SGC-996 cells 0–100 mM 24 hours, 48 hours, 72 hours ISL significantly inhibited the proliferation of SGC-996 cells, with IC50 values of 210.1 mmol/L at 24 h, 72.9 mmol/L at 48 h, and 51.9 mmol/L at 72 h. Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220.
HiBECs cells 50 mM, 70 mM 48 hours ISL at 50 mmol/L and 70 mmol/L did not significantly alter the growth of HiBECs cells. Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220.
L-2F7 cells 50 mM, 70 mM 48 hours ISL at 50 mmol/L and 70 mmol/L did not significantly alter the growth of L-2F7 cells. Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220.
U87 cells 5 µM 48 hours To investigate the effects of ISL on circRNA expression, it was found that ISL significantly downregulated circ0030018 expression MedComm (2020). 2023 May 26;4(3):e282.
SHG44 cells 5 µM 48 hours To investigate the effects of ISL on circ0030018 expression, it was found that ISL significantly downregulated circ0030018 expression MedComm (2020). 2023 May 26;4(3):e282.
Mouse primary bone marrow-derived macrophages (BMMs) 16 or 64 μg/mL 5 days MSNs-ISL significantly inhibited RANKL-induced osteoclast generation, decreased the size and quantity of sealing zones, and reduced the osteolytic capacity of osteoclasts in vitro. Theranostics. 2019 Jul 9;9(18):5183-5199.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57/BL6 mice LPS-mediated calvarial bone erosion model Subcutaneous injection 50 mg/kg Once every 2 days for 7 days MSNs-ISL could block osteoclast activity, relieve inflammation-related calvarial bone destruction in vivo, and suppress c-Fos, NFATc1, and cathepsin K expression levels. Theranostics. 2019 Jul 9;9(18):5183-5199.
BALB/c Nude mice NOZ cell xenograft model Gavage 50 mg/kg Every 2 days for 28 days ISL significantly inhibited tumor growth in the NOZ cell xenograft model, reducing tumor volume to less than 10% of the control group. HMOX1-deficient or GPX4-overexpressing NOZ cells partially reversed the inhibitory effect of ISL. Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.90mL

0.78mL

0.39mL

19.51mL

3.90mL

1.95mL

39.02mL

7.80mL

3.90mL

References

 

Historical Records

Categories